Radiotherapy in bladder cancer.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Radiotherapy and Oncology

• Publication date

  1999-07-01

• Fields of study

  Medicine, Physics

• Identifiers
  DOI 10.1016/S0167-8140(99)00090-0PMID 10577680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.

  1999cited by this paper
• Planned preoperative radiation therapy in muscle invasive bladder cancer; results of a meta-analysis.

  1998cited by this paper
• Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control.

  1998cited by this paper
• Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer.

  1998cited by this paper
• Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of radiation therapy oncology group 89-03.

  1998cited by this paper
• Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study.

  1997cited by this paper
• Treatment outcome following radiotherapy in elderly patients with bladder cancer.

  1997cited by this paper
• Morbidity after preoperative radiotherapy and cystectomy in patients with bladder cancer.

  1997cited by this paper
• Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192.

  1997cited by this paper
• Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly.

  1997cited by this paper
• Neoadjuvant and adjuvant chemotherapy in locally advanced bladder cancer.

  1997cited by this paper
• Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.

  1997cited by this paper
• Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer.

  1997cited by this paper
• Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment

  1997cited by this paper
• Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study.

  1997cited by this paper
• Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment.

  1997cited by this paper
• Hypofractionated radiotherapy for invasive bladder cancer.

  1997cited by this paper
• Bladder movement during radiation therapy for bladder cancer: implications for treatment planning.

  1997cited by this paper
• Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.

  1997cited by this paper
• Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.

  1996cited by this paper
• Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study.

  1996cited by this paper
• Results of radical cystectomy and pelvic lymphadenectomy for bladder cancer with pelvic node metastases.

  1996cited by this paper
• Five-year Followup of a Prospective Trial of Radical Cystectomy and Neoadjuvant Chemotherapy: Nordic Cystectomy Trial 1

  1996cited by this paper
• High-dose pelvic irradiation followed by ileal neobladder urinary diversion: complications and long-term results.

  1996cited by this paper
• Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma: A survey by a self‐administered questionnaire

  1996cited by this paper
• Assessment of functional status in patients with invasive carcinoma of the urothelial tract.

  1996cited by this paper
• Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group.

  1996cited by this paper
• Neoadjuvant and adjuvant chemotherapy in locally advanced bladder cancer.

  1996cited by this paper
• Predictive value of DNA ploidy in bladder cancer treated with preoperative radiation therapy and cystectomy.

  1996cited by this paper
• Early complications and survival following short-term palliative radiotherapy in invasive bladder carcinoma.

  1996cited by this paper
• Once weekly irradiation for carcinoma of the bladder.

  1996cited by this paper
• Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy.

  1996cited by this paper
• Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced bladder cancer overview collaboration.

  1995cited by this paper
• Immunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: positive immunostaining and radiosensitivity.

  1995cited by this paper
• Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up.

  1995cited by this paper
• p53 and Rb immunostaining in locally advanced bladder cancer: relation to prognostic variables and predictive value for the local response to radical radiotherapy.

  1995cited by this paper
• Split course radiotherapy for bladder cancer in elderly unfit patients.

  1995cited by this paper
• Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.

  1995cited by this paper
• Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced Bladder Cancer Overview Collaboration.

  1995cited by this paper
• The value of three-dimensional radiotherapy planning in advanced carcinoma of the urinary bladder based on computed tomography.

  1994cited by this paper
• Complications of Combined Radiotherapy and Chemotherapy.

  1994cited by this paper
• Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors.

  1994cited by this paper
• Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial.

  1994cited by this paper
• Organ-sparing treatment of advanced bladder cancer: a 10-year experience.

  1994cited by this paper
• Bladder conservation in selected T1G3 and muscle-invasive T2-T3a bladder carcinoma using combination therapy of surgery and iridium-192 implantation.

  1994cited by this paper
• Sequential transurethral surgery, multiple drug chemotherapy and radiation therapy for invasive bladder carcinoma: initial report.

  1993cited by this paper
• Changes in target volume during radiotherapy treatment of invasive bladder carcinoma.

  1993cited by this paper
• Combined radiation therapy and cisplatin for locally advanced carcinoma of the urinary bladder

  1993cited by this paper
• Survival of Danish cancer patients 1943-1987. Urinary tract.

  1993cited by this paper
• Neoadjuvant chemotherapy in bladder cancer: a randomized study. Nordic Cystectomy Trial I.

  1993cited by this paper
• Selective bladder preservation by combination treatment of invasive bladder cancer.

  1993cited by this paper
• Predicting the outcome of radical radiotherapy for invasive bladder cancer.

  1993cited by this paper
• Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12.

  1993cited by this paper
• Bladder cancer definitive radiation therapy of muscle‐invasive bladder cancer: A retrospective analysis of 317 patients

  1993cited by this paper
• Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.

  1993cited by this paper
• The Risk of Determining Risk with Multivariable Models

  1993cited by this paper
• Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer.

  1992cited by this paper
• Interstitial iridium-192 for bladder cancer (a multicentric survey: 205 patients).

  1992cited by this paper
• The quality of life after radical radiotherapy for bladder cancer.

  1992cited by this paper
• Unconventional fractionation for palliative radiotherapy of urinary bladder cancer. A retrospective review of 94 patients.

  1992cited by this paper
• A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

  1992cited by this paper
• T1 and T2 carcinoma of the urinary bladder: long term results with external, preoperative, or interstitial radiotherapy.

  1992cited by this paper
• Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study.

  1992cited by this paper
• Radical radiotherapy with salvage surgery for invasive bladder cancer: results following a reduction in radiation dose.

  1992cited by this paper
• Modelling altered fractionation schedules.

  1992cited by this paper
• Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: a possible predictor for successful bladder preservation following transurethral surgery and chemotherapy-radiotherapy.

  1992cited by this paper
• The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial.

  1991cited by this paper
• Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy.

  1991cited by this paper
• Short-term moderate-dose pelvic radiotherapy of advanced bladder carcinoma. A questionnaire-based evaluation of its symptomatic effect.

  1991cited by this paper
• Short-term radiotherapy as palliative treatment in patients with transitional cell bladder cancer.

  1991cited by this paper
• Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report).

  1991cited by this paper
• Bladder carcinoma--a 20-year review of radical irradiation therapy.

  1991cited by this paper
• Dose fractionation and tumour repopulation in radiotherapy for bladder cancer.

  1991cited by this paper
• Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group.

  1991cited by this paper
• Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy.

  1990cited by this paper
• Prediction of response to radiotherapy in invasive bladder cancer.

  1990cited by this paper
• Assessment of factors influencing the outcome of radiotherapy for bladder cancer.

  1990cited by this paper
• A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.

  1990cited by this paper
• Long-term morbidity after curative radiotherapy for carcinoma of the bladder. A retrospective study.

  1990cited by this paper
• Evaluation of tumor response in patients with bladder cancer undergoing combined radiotherapy and chemotherapy.

  1990cited by this paper
• Prognostic factors in patients with bladder carcinoma treated with definitive irradiation

  1990cited by this paper
• The NCI-Canada trial of concurrent cisplatin and radiotherapy for muscle invasive bladder cancer.

  1990cited by this paper
• External beam radiation treatment of urinary bladder carcinoma. An analysis of results in 203 patients.

  1990cited by this paper
• Imaging of invasive bladder cancer.

  1990cited by this paper
• Long-term morbidity after curative radiotherapy for carcinoma of the bladder. A retrospective study.

  1990cited by this paper
• Role of planned preoperative irradiation in the management of clinical stage B2-C (T3) bladder carcinoma in the 1980s.

  1989cited by this paper
• Split-course radiotherapy for urinary bladder cancer.

  1989cited by this paper
• Prognostic factors in a T3 bladder cancer trial. Co-operative Urological Cancer Group.

  1989cited by this paper
• Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis.

  1989cited by this paper
• Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen.

  1989cited by this paper
• A controlled trial of misonidazole in the curative treatment of infiltrating bladder cancer.

  1989cited by this paper
• Urinary diversion using the Kock ileal reservoir in patients with irradiated bowel.

  1988cited by this paper
• Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx.

  1988cited by this paper
• How expert physicians would wish to be treated if they had genitourinary cancer.

  1988cited by this paper
• Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer.

  1988cited by this paper
• Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83-08 of the Radiation Therapy Oncology Group.

  1988cited by this paper
• Conservative management of muscle-infiltrating bladder cancer: prospective experience.

  1987cited by this paper
• Treatment of invasive grade 3 transitional cell bladder cancer. A retrospective study of 10 years' experience with external irradiation, and preoperative irradiation and cystectomy.

  1987cited by this paper
• Multivariate survival analysis using Cox's regression model

  1987cited by this paper
• Invasive bladder carcinoma. The importance of initial transurethral surgery and other significant prognostic factors for improved survival with full‐dose irradiation

  1987cited by this paper

• Trimodality Therapy in which Concurrent Chemoradiation with Concomitant Boost in Muscle Invasive TCC Urinary Bladder Cancer

  2023cites this paper
• What is the Optimal Dose, Fractionation and Volume for Bladder Radiotherapy?

  2021cites this paper
• Prospective evaluation of definitive chemoradiotherapy with volumetric modulated arc therapy in patients with muscle invasive carcinoma of urinary bladder

  2020cites this paper
• [Adaptive radiotherapy: Strategies and benefits depending on tumor localization].

  2019cites this paper
• Assessing Radiosensitivity of Bladder Cancer in vitro: A 2D vs. 3D Approach

  2019cites this paper
• Involved-field irradiation for elderly bladder cancer patients.

  2019cites this paper
• A review of plan library approaches in adaptive radiotherapy of bladder cancer

  2018cites this paper
• Target Volume Delineation Guidelines in Bladder Cancer

  2017cites this paper
• Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers

  2017cites this paper
• Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study.

  2016cites this paper
• Chapter 54 – Bladder Cancer

  2016cites this paper
• Muscle-invasive bladder cancer treated with TURB followed by concomitant boost with small reduction of radiotherapy field with or without of chemotherapy.

  2016cites this paper
• Investigation of temperature dependence of semiconductor detectors used in medicine for radiation measurements

  2015cites this paper
• Long-term results of a concomitant boost radiotherapy technique for elderly patients with muscle-ınvasive bladder cancer.

  2015cites this paper
• Accounting for imprecisions in image-guided radiotherapy: bladder cancer as an example

  2015cites this paper
• Bladder Cancer Treatment: Review of Literature

  2015cites this paper
• Defining bowel dose volume constraints for bladder radiotherapy treatment planning.

  2015cites this paper
• Long-term outcomes in treatment of invasive bladder cancer with concomitant boost and accelerated hyperfractionated radiation therapy.

  2014cites this paper
• Rola teleradioterapii w inwazyjnym raku pęcherza moczowego

  2014influential citation
• Evaluation of efficacy and toxicity in two different hypofractionated 3D-conformal external beam radiotherapy schedules in localised muscle invasive bladder cancer.

  2013cites this paper
• Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

  2013cites this paper
• Australian & New Zealand Faculty of Radiation Oncology Genito‐Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder

  2012cites this paper
• A randomised double-blind placebo-controlled trial to determine the effect of cranberry juice on decreasing the incidence of urinary symptoms and urinary tract infections in patients undergoing radiotherapy for cancer of the bladder or cervix.

  2012cites this paper
• The Surgical Management of Invasive Bladder Cancer

  2012cites this paper
• Cyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.

  2011cites this paper
• Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Bladder Cancer

  2011cites this paper
• Behavior of lipiodol markers during image guided radiotherapy of bladder cancer.

  2010cites this paper
• External beam radiotherapy of bladder carcinoma: considerations in determining the irradiation field margins.

  2010cites this paper
• Les vraies contre-indications du BCG dans le traitement des tumeurs de vessie

  2010cites this paper
• A study of image-guided radiotherapy of bladder cancer based on lipiodol injection in the bladder wall

  2010cites this paper
• Trimodality treatment for bladder cancer: does modern radiotherapy improve the end results?

  2010cites this paper
• [Bladder tumour treatment: the real BCG definitive contra-indications].

  2010cites this paper
• Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma

  2009cites this paper
• Radiation therapy in urinary cancer: state of the art and perspective

  2009cites this paper
• Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer.

  2009cites this paper
• The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy

  2009cites this paper
• Conservative treatment in patients with muscle-invasive bladder cancer by transurethral resection, neoadjuvant chemotherapy with gemcitabine and cisplatin, and accelerated radiotherapy with concomitant boost plus concurrent cisplatin – assessment of response and toxicity.

  2008cites this paper
• Clinical Results of a Concomitant Boost Radiotherapy Technique for Muscle-Invasive Bladder Cancer

  2008cites this paper
• Assessing intra-fractional bladder motion using cine-MRI as initial methodology for Predictive Organ Localization (POLO) in radiotherapy for bladder cancer.

  2007cites this paper
• Bladder Cancer: Management and Future Directions

  2007cites this paper
• Tumor motion and deformation during external radiotherapy of bladder cancer.

  2006cites this paper
• MANAGEMENT OF MUSCLE‐INVASIVE BLADDER CANCER IN VICTORIA, 1990–1995

  2006cites this paper
• Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution.

  2006cites this paper
• Radical radiotherapy for invasive bladder cancer: What dose and fractionation schedule to choose?

  2006cites this paper
• Anaemia is associated with poor overall survival but not with inferior local control in patients with muscle invasive bladder carcinoma treated by radical external beam radiotherapy. A retrospective study.

  2006cites this paper
• Bladder filling variation during radiation treatment of prostate cancer: can the use of a bladder ultrasound scanner and biofeedback optimize bladder filling?

  2006cites this paper
• Radiation therapy for muscle-invasive bladder cancer: treatment planning and delivery in the 21st century.

  2005cites this paper
• Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?

  2005cites this paper
• Adaptive radiotherapy for invasive bladder cancer: a feasibility study.

  2005cites this paper
• Application of targeted radiotherapy/gene therapy to bladder cancer cell lines.

  2005cites this paper
• Radiation therapy for muscle-invasive bladder cancer: treatment planning and delivery.

  2005cites this paper
• Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer.

  2004cites this paper
• Clinical radiobiology of stage T2-T3 bladder cancer.

  2004cites this paper
• Treatment margins and treatment fractionation in conformal radiotherapy of muscle-invading urinary bladder cancer.

  2004cites this paper
• Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer

  2004cites this paper
• Conformal radiotherapy of urinary bladder cancer.

  2004influential citation
• A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice?

  2004cites this paper
• Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer.

  2004cites this paper
• [Neuroendocrine differentiation of bladder tumors].

  2003cites this paper
• Low‐dose radiotherapy (LD‐RT) and the modulation of iNOS expression in adjuvant‐induced arthritis in rats

  2003cites this paper
• A study of the effects of internal organ motion on dose escalation in conformal prostate treatments.

  2003cites this paper
• Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer.

  2003cites this paper
• Prognostic Factors, Pattern of Recurrence and Survival in a Danish Bladder Cancer Cohort Treated with Radical Cystectomy

  2003cites this paper
• Concomitant boost radiotherapy for muscle invasive bladder cancer.

  2003influential citation
• Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer.

  2003cites this paper
• Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer

  2003cites this paper
• Patología neoplásica del urotelio

  2002cites this paper
• Neoadjuvant Chemotherapy with Cisplatin and Methotrexate in Patients with Muscle-Invasive Bladder Tumours

  2002cites this paper
• Distressful symptoms after radical radiotherapy for urinary bladder cancer.

  2002cites this paper
• Cell Cycle Inhibitors and Outcome after Radiotherapy in Bladder Cancer Patients

  2002cites this paper
• Muscle-Invasive Bladder Cancer in Elderly-Unfit Patients with Concomitant Illness: Can a Curative Radiation Therapy be Delivered?

  2002cites this paper
• [Neoplastic pathology of the urothelium].

  2002cites this paper
• Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique.

  2002cites this paper
• ARCON: a novel biology-based approach in radiotherapy.

  2002cites this paper
• BCG Therapy—related Death and Previous Pelvic Radiation

  2001cites this paper
• Partially wedged beams improve radiotherapy treatment of urinary bladder cancer.

  2001cites this paper
• p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder

  2001cites this paper
• Radiation injury of the rectum.

  2001cites this paper
• Orthotopic Neobladder Following Cystectomy: Indications, Management, and Outcomes

  2001cites this paper
• Blasencarcinome und Carcinome des Übergangsepithels

  2001cites this paper
• TP53 and p21WAF1/CIP1 behave differently in euploid versus aneuploid bladder tumours treated with radiotherapy.

  2001cites this paper
• Volume effects in radiobiology as applied to radiotherapy.

  2000cites this paper